We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNFT
1276
DELISTED
Benefitfocus, Inc.
BNFT
$81K ﹤0.01%
2,929
ZEN
1277
DELISTED
ZENDESK INC
ZEN
$81K ﹤0.01%
2,900
ICLR icon
1278
Icon
ICLR
$13B
$80K ﹤0.01%
1,005
+275
+38% +$22.5K
ECOL
1279
DELISTED
US Ecology, Inc.
ECOL
$79K ﹤0.01%
1,712
CERS icon
1280
Cerus
CERS
$615M
$78K ﹤0.01%
17,696
+5,700
+48% +$24.2K
CSL icon
1281
Carlisle Companies
CSL
$13.8B
$78K ﹤0.01%
739
-184,501
-100% -$19.8M
LGND icon
1282
Ligand Pharmaceuticals
LGND
$5.96B
$78K ﹤0.01%
1,193
+74
+7% +$4.87K
MFIC icon
1283
MidCap Financial Investment
MFIC
$790M
$78K ﹤0.01%
4,000
NMR icon
1284
Nomura Holdings
NMR
$28.6B
$78K ﹤0.01%
12,627
-1,512
-11% -$9.69K
LVLT
1285
DELISTED
Level 3 Communications Inc
LVLT
$78K ﹤0.01%
1,368
-50
-4% -$2.89K
MAGN
1286
Magnera Corp
MAGN
$490M
$77K ﹤0.01%
277
ETW
1287
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
$76K ﹤0.01%
6,995
AES.PRC.CL
1288
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$76K ﹤0.01%
1,500
PDS
1289
Precision Drilling
PDS
$1.04B
$75K ﹤0.01%
802
MNST icon
1290
Monster Beverage
MNST
$93.2B
$74K ﹤0.01%
3,246
PNR icon
1291
Pentair
PNR
$10.2B
$74K ﹤0.01%
1,782
+107
+6% +$4.28K
INXN
1292
DELISTED
Interxion Holding N.V.
INXN
$73K ﹤0.01%
1,870
NTP
1293
DELISTED
Nam Tai Property Inc.
NTP
$73K ﹤0.01%
10,600
+10,470
+8,054% +$76.5K
VRSK icon
1294
Verisk Analytics
VRSK
$27.1B
$72K ﹤0.01%
900
HSEA.CL
1295
DELISTED
HSBC Holdings plc
HSEA.CL
$72K ﹤0.01%
2,708
CGNX icon
1296
Cognex
CGNX
$10.2B
$71K ﹤0.01%
1,700
+800
+89% +$29.3K
CWI icon
1297
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.75B
$71K ﹤0.01%
3,170
-150
-5% -$3.32K
FTS icon
1298
Fortis
FTS
$29.7B
$71K ﹤0.01%
2,170
+1,500
+224% +$47.9K
LBRDK icon
1299
Liberty Broadband Class C
LBRDK
$4.44B
$71K ﹤0.01%
836
-26
-3% -$2.17K
WWAV
1300
DELISTED
The WhiteWave Foods Company
WWAV
$71K ﹤0.01%
1,270

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.